Depression is an early disease manifestation in lupus-prone MRL/lpr mice

Journal of Neuroimmunology

Volumn 207, Issue 1-2, 2009, Pages 45-56

  Gao, Hua Xin ^a   Campbell, Sean R ^a   Cui, Min Hui ^a   Zong, Pu ^a   hee Hwang, Jong ^a   Gulinello, Maria ^a   Putterman, Chaim ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Anti DNA antibodies; Depression; Neuropsychiatric lupus; Systemic Lupus Erythematosus

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANXIETY; ARTICLE; BRAIN METABOLISM; COGNITION; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; FEMALE; FORCED SWIMMING TEST; LOCOMOTION; MAZE TEST; MOTOR COORDINATION; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NEUROIMAGING; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEINURIA; SOCIAL BEHAVIOR; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL MEMORY; WORKING MEMORY;

ANIMALS; ASPARTIC ACID; AUTOANTIBODIES; BRAIN; CARDIOLIPINS; CHOLINE; CHROMATIN; CREATINE; DEPRESSION; DNA; EXPLORATORY BEHAVIOR; FEMALE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MAZE LEARNING; MICE; MICE, MUTANT STRAINS; PROTEINURIA; PSYCHOMOTOR PERFORMANCE; RECEPTORS, N-METHYL-D-ASPARTATE; RECOGNITION (PSYCHOLOGY); SOCIAL BEHAVIOR; SWIMMING;

EID: 60149109686     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.11.009     Document Type: Article

References (66)

1. Bessa J.M., Oliveira M., Cerqueira J.J., Almeida O.F., and Sousa N. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze. Behav. Brain Res. 162 (2005) 135-142
2. Bluestein H.G. The central nervous system in systemic lupus erythematosus. In: Lahita R.G. (Ed). Systemic lupus erythematosus (1992), Churchill Livingstone, New York 639-655
3. Bonfa E., Marshak-Rothstein A., Weissbach H., Brot N., and Elkon K. Frequency and epitope recognition of anti-ribosome P antibodies from humans with systemic lupus erythematosus and MRL/lpr mice are similar. J. Immunol. 140 (1988) 3434-3437
4. Brey R.L., Abbott R.D., Curb J.D., Sharp D.S., Ross G.W., Stallworth C.L., and Kittner S.J. beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the Honolulu heart program. Stroke 32 (2001) 1701-1706
5. Brooks W.M., Sabet A., Sibbitt Jr. W.L., Barker P.B., van Zijl P.C., Duyn J.H., and Moonen C.T. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J. Rheumatol. 24 (1997) 2323-2329
6. Chu J.L., Drappa J., Parnassa A., and Elkon K.B. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J. Exp. Med. 178 (1993) 723-730
7. Cohen-Solal J.F., Jeganathan V., Grimaldi C.M., Peeva E., and Diamond B. Sex hormones and SLE: influencing the fate of autoreactive B cells. Curr. Top. Microbiol. Immunol. 305 (2006) 67-88
8. Dantzer R., Bluthe R.M., Koob G.F., and Le Moal M. Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology 91 (1987) 363-368
9. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., and Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7 (2001) 1189-1193
10. Deocharan B., Qing X., Beger E., and Putterman C. Antigenic triggers and molecular targets for anti-double-stranded DNA antibodies. Lupus 11 (2002) 865-871
11. Deocharan B., Zhou Z., Antar K., Siconolfi-Baez L., Angeletti R.H., Hardin J., and Putterman C. Alpha-actinin immunization elicits anti-chromatin autoimmunity in nonautoimmune mice. J. Immunol. 179 (2007) 1313-1321
12. Eber T., Chapman J., and Shoenfeld Y. Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?. Lupus 14 (2005) 571-575
13. Elkon K.B., Bonfa E., Llovet R., and Eisenberg R.A. Association between anti-Sm and anti-ribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice. J. Immunol. 143 (1989) 1549-1554
14. Emmer B.J., van der Grond J., Steup-Beekman G.M., Huizinga T.W., and van Buchem M.A. Selective involvement of the amygdala in systemic lupus erythematosus. PLoS. Med. 3 (2006) e499
15. Ennaceur A., Neave N., and Aggleton J.P. Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp. Brain Res. 113 (1997) 509-519
16. Fragoso-Loyo H., Richaud-Patin Y., Orozco-Narvaez A., Davila-Maldonado L., Atisha-Fregoso Y., Llorente L., and Sanchez-Guerrero J. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum. 56 (2007) 1242-1250
17. Garwood M., and DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J. Magn. Reson. 153 (2001) 155-177
18. Gorelick P.B. Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review. Stroke 33 (2002) 862-875
19. Grimaldi C.M. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells. Curr. Opin. Rheumatol. 18 (2006) 456-461
20. Hermosillo-Romo D., and Brey R.L. Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Best. Pract. Res. Clin. Rheumatol. 16 (2002) 229-244
21. Hess D.C., Taormina M., Thompson J., Sethi K.D., Diamond B., Rao R., Chamberlain C.R., and Feldman D.S. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J. Rheumatol. 20 (1993) 610-617
22. Huerta P.T., Kowal C., DeGiorgio L.A., Volpe B.T., and Diamond B. Immunity and behavior: antibodies alter emotion. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 678-683
23. Katzav A., Solodeev I., Brodsky O., Chapman J., Pick C.G., Blank M., Zhang W., Reichlin M., and Shoenfeld Y. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum. 56 (2007) 938-948
24. Kowal C., DeGiorgio L.A., Nakaoka T., Hetherington H., Huerta P.T., Diamond B., and Volpe B.T. Cognition and immunity; antibody impairs memory. Immunity 21 (2004) 179-188
25. Kowal C., Degiorgio L.A., Lee J.Y., Edgar M.A., Huerta P.T., Volpe B.T., and Diamond B. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 19854-19859
26. Lahita R.G. The role of sex hormones in systemic lupus erythematosus. Curr. Opin. Rheumatol. 11 (1999) 352-356
27. Lapteva L., Nowak M., Yarboro C.H., Takada K., Roebuck-Spencer T., Weickert T., Bleiberg J., Rosenstein D., Pao M., Patronas N., Steele S., Manzano M., van der Veen J.W., Lipsky P.E., Marenco S., Wesley R., Volpe B., Diamond B., and Illei G.G. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum. 54 (2006) 2505-2514
28. Lawrence D.A., Bolivar V.J., Hudson C.A., Mondal T.K., and Pabello N.G. Antibody induction of lupus-like neuropsychiatric manifestations. J. Neuroimmunol. 182 (2007) 185-194
29. Leritz E., Brandt J., Minor M., Reis-Jensen F., and Petri M. "Subcortical" cognitive impairment in patients with systemic lupus erythematosus. J. Int. Neuropsychol. Soc. 6 (2000) 821-825
30. Miyasaka N., Takahashi K., and Hetherington H.P. 1H NMR spectroscopic imaging of the mouse brain at 9.4 T. J. Magn. Reson. Imaging. 24 (2006) 908-913
31. Montes G.S., and Luque E.H. Effects of ovarian steroids on vaginal smears in the rat. Acta Anat. 133 (1988) 192-199
32. Muscal E., and Myones B.L. The role of autoantibodies in pediatric neuropsychiatric systemic lupus erythematosus. Autoimmun. Rev. 6 (2007) 215-217
33. Nery F.G., Borba E.F., Viana V.S., Hatch J.P., Soares J.C., Bonfa E., and Neto F.L. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies. Prog. Neuropsychopharmacol. Biol. Psychiatry. 32 (2008) 695-700
34. Pan J.W., Kim J.H., Cohen-Gadol A., Pan C., Spencer D.D., and Hetherington H.P. Regional energetic dysfunction in hippocampal epilepsy. Acta Neurol. Scand. 111 (2005) 218-224
35. Pause B.M., Miranda A., Goder R., Aldenhoff J.B., and Ferstl R. Reduced olfactory performance in patients with major depression. J. Psychiatr. Res. 35 (2001) 271-277
36. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14 (1985) 149-167
37. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J. Autoimmun. 15 (2000) 145-151
38. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229 (1977) 327-336
39. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
40. Putterman C. New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus. Autoimmun. Rev. 3 (2004) 7-11
41. Putterman C., and Diamond B. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J. Exp. Med. 188 (1998) 29-38
42. Rudofsky U.H., and Lawrence D.A. New Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects. Environ. Health. Perspect 107 Suppl. 5 (1999) 713-721
43. Rudofsky U.H., Evans B.D., Balaban S.L., Mottironi V.D., and Gabrielsen A.E. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab. Invest. 68 (1993) 419-426
44. Sakic B., Szechtman H., Keffer M., Talangbayan H., Stead R., and Denburg J.A. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav. Immun. 6 (1992) 265-285
45. Sakic B., Szechtman H., Denburg S., Carbotte R., and Denburg J.A. Spatial learning during the course of autoimmune disease in MRL mice. Behav. Brain Res. 54 (1993) 57-66
46. Sakic B., Szechtman H., Talangbayan H., Denburg S.D., Carbotte R.M., and Denburg J.A. Disturbed emotionality in autoimmune MRL-lpr mice. Physiol. Behav. 56 (1994) 609-617
47. Sakic B., Szechtman H., Stead R.H., and Denburg J.A. Joint pathology and behavioral performance in autoimmune MRL-lpr Mice. Physiol. Behav. 60 (1996) 901-905
48. Sakic B., Szechtman H., Braciak T., Richards C., Gauldie J., and Denburg J.A. Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res. Bull. 44 (1997) 155-165
49. Sakic B., Szechtman H., and Denburg J.A. Neurobehavioral alterations in autoimmune mice. Neurosci. Biobehav. Rev. 21 (1997) 327-340
50. Schneebaum A.B., Singleton J.D., West S.G., Blodgett J.K., Allen L.G., Cheronis J.C., and Kotzin B.L. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am. J. Med. 90 (1991) 54-62
51. Schrott L.M., and Crnic L.S. Anxiety behavior, exploratory behavior, and activity in NZB × NZW F1 hybrid mice: role of genotype and autoimmune disease progression. Brain Behav. Immun. 10 (1996) 260-274
52. Shoenfeld Y. To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. J. Autoimmun. 28 (2007) 165-169
53. Shoenfeld Y., Nahum A., Korczyn A.D., Dano M., Rabinowitz R., Beilin O., Pick C.G., Leider-Trejo L., Kalashnikova L., Blank M., and Chapman J. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12 (2003) 436-442
54. Sibbitt Jr. W.L., and Sibbitt R.R. Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatric systemic lupus erythematosus. Rheum. Dis. Clin. North. Am. 19 (1993) 851-868
55. Sibbitt Jr. W.L., Haseler L.J., Griffey R.H., Hart B.L., Sibbitt R.R., and Matwiyoff N.A. Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy. AJNR. Am. J. Neuroradiol. 15 (1994) 923-928
56. Sibbitt Jr. W.L., Haseler L.J., Griffey R.R., Friedman S.D., and Brooks W.M. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. AJNR. Am. J. Neuroradiol. 18 (1997) 1271-1277
57. Sidor M.M., Sakic B., Malinowski P.M., Ballok D.A., Oleschuk C.J., and Macri J. Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice. J. Neuroimmunol. 165 (2005) 104-113
58. Stojanovich L., Zandman-Goddard G., Pavlovich S., and Sikanich N. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun. Rev. 6 (2007) 421-426
59. Theofilopoulos A.N. Murine models of lupus. In: Lahita R.G. (Ed). Systemic lupus erythematosus (1992), Churchill Livingstone, New York 121-194
60. Toubi E., and Shoenfeld Y. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun. Rev. 6 (2007) 119-125
61. Twieg D.B., Meyerhoff D.J., Hubesch B., Roth K., Sappey-Marinier D., Boska M.D., Gober J.R., Schaefer S., and Weiner M.W. Phosphorus-31 magnetic resonance spectroscopy in humans by spectroscopic imaging: localized spectroscopy and metabolite imaging. Magn. Reson. Med. 12 (1989) 291-305
62. Vogelweid C.M., Johnson G.C., Besch-Williford C.L., Basler J., and Walker S.E. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. J. Neuroimmunol. 35 (1991) 89-99
63. Wekking E.M. Psychiatric symptoms in systemic lupus erythematosus: an update. Psychosom. Med. 55 (1993) 219-228
64. Zandman-Goddard G., Chapman J., and Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin. Arthritis. Rheum. 36 (2007) 297-315
65. Ziporen L., Shoenfeld Y., Levy Y., and Korczyn A.D. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A. mouse. model. J. Clin. Invest. 100 (1997) 613-619
66. Zueger M., Urani A., Chourbaji S., Zacher C., Roche M., Harkin A., and Gass P. Olfactory bulbectomy in mice induces alterations in exploratory behavior. Neurosci. Lett. 374 (2005) 142-146